Intuitive Surgical, Inc. (ISRG) Insider Trading Activity

NASDAQ$538.51-2.83 (-0.52%)
Market Cap
$193.38B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
654 of 893
Rank in Industry
34 of 49

ISRG Insider Trading Activity

ISRG Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$80,523,021
56
100

Related Transactions

BARRATT CRAIG Hdirector
0
$0
1
$435,000
$-435,000
Widman FredrikVP Corporate Controller
0
$0
2
$552,212
$-552,212
NACHTSHEIM JAMI Kdirector
0
$0
1
$1.25M
$-1.25M
Ladd Amy Ldirector
0
$0
4
$1.25M
$-1.25M
LOEB GARYEVP & Chief Legal and Complian
0
$0
2
$1.63M
$-1.63M
Brosius MarkSVP & Chief Mfg and Supply Cha
0
$0
17
$2.45M
$-2.45M
Johnson Amal Mdirector
0
$0
1
$2.63M
$-2.63M
Samath JamieEVP & CFO & Enterprise Technol
0
$0
6
$4.28M
$-4.28M
Charlton Henry LEVP & Chief Commercial and Mkt
0
$0
1
$4.43M
$-4.43M
DeSantis RobertEVP & Chief Strategy & Corp Op
0
$0
4
$4.7M
$-4.7M
Miller Brian EdwardEVP & Chief Digital Officer
0
$0
3
$6.84M
$-6.84M
Curet MyriamEVP & Chief Medical Officer
0
$0
10
$8.67M
$-8.67M
Rosa David J.President
0
$0
1
$9.2M
$-9.2M
GUTHART GARY SExecutive Chair of the Board o
0
$0
3
$32.21M
$-32.21M

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Insider Activity of Intuitive Surgical, Inc.

Over the last 12 months, insiders at Intuitive Surgical, Inc. have bought $0 and sold $80.52M worth of Intuitive Surgical, Inc. stock.

On average, over the past 5 years, insiders at Intuitive Surgical, Inc. have bought $0 and sold $97.07M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,000 shares for transaction amount of $500,373 was made by Johnson Amal M (director) on 2010‑11‑19.

List of Insider Buy and Sell Transactions, Intuitive Surgical, Inc.

2025-12-15SaleBrosius MarkSVP & Chief Mfg and Supply Cha
464
0.0001%
$548.49
$254,499
+3.16%
2025-12-12SaleBrosius MarkSee Remarks
312
<0.0001%
$547.36
$170,776
+5.00%
2025-12-10SaleCuret MyriamEVP & Chief Medical Officer
104
<0.0001%
$559.90
$58,230
+2.23%
2025-12-01SaleGUTHART GARY SExecutive Chair of the Board o
22,806
0.0064%
$570.89
$13.02M
-0.57%
2025-12-01SaleCuret MyriamEVP & Chief Medical Officer
125
<0.0001%
$568.99
$71,124
-0.57%
2025-11-12SaleCharlton Henry LEVP & Chief Commercial and Mkt
7,632
0.0022%
$580.00
$4.43M
-0.98%
2025-11-12SaleBARRATT CRAIG Hdirector
750
0.0002%
$580.00
$435,000
-0.98%
2025-11-10SaleMiller Brian EdwardEVP & Chief Digital Officer
2,202
0.0006%
$575.00
$1.27M
-1.61%
2025-11-10SaleCuret MyriamEVP & Chief Medical Officer
105
<0.0001%
$560.00
$58,800
-1.61%
2025-11-05SaleWidman FredrikVP Corporate Controller
159
<0.0001%
$550.00
$87,450
+3.34%
2025-10-29SaleCuret MyriamEVP & Chief Medical Officer
125
<0.0001%
$543.00
$67,875
+5.19%
2025-10-28SaleCuret MyriamEVP & Chief Medical Officer
1,379
0.0004%
$548.43
$756,279
+3.64%
2025-09-04SaleLadd Amy Ldirector
335
<0.0001%
$440.69
$147,631
+20.40%
2025-09-03SaleLadd Amy Ldirector
336
<0.0001%
$470.11
$157,957
+23.92%
2025-08-29SaleGUTHART GARY SExecutive Chair of the Board o
29,360
0.0082%
$472.49
$13.87M
+15.47%
2025-07-28SaleGUTHART GARY SExecutive Chair of the Board o
10,693
0.003%
$497.75
$5.32M
+1.33%
2025-07-25SaleCuret MyriamEVP & Chief Medical Officer
4,500
0.0012%
$492.48
$2.22M
+0.57%
2025-06-06SaleBrosius MarkSVP & Chief Mfg and Supply Cha
216
<0.0001%
$563.11
$121,632
-7.30%
2025-06-05SaleBrosius MarkSVP & Chief Mfg and Supply Cha
215
<0.0001%
$560.70
$120,551
-7.26%
2025-06-04SaleBrosius MarkSVP & Chief Mfg and Supply Cha
215
<0.0001%
$552.07
$118,695
-7.05%
Total: 783
*Gray background shows transactions not older than one year

Insider Historical Profitability

29.94%
Rosa David J.President
225438
0.0631%
$122.04M023
Johnson Amal Mdirector
12275
0.0034%
$6.64M220
+29.94%
Samath JamieSee Remarks
7162
0.002%
$3.88M055
NACHTSHEIM JAMI Kdirector
6371
0.0018%
$3.45M02
Miller Brian EdwardEVP & Chief Digital Officer
5758
0.0016%
$3.12M05
DeSantis RobertEVP & Chief Strategy & Corp Op
5224
0.0015%
$2.83M040
Charlton Henry LEVP & Chief Commercial and Mkt
3056
0.0009%
$1.65M03
GUTHART GARY SExecutive Chair of the Board o
2694
0.0008%
$1.46M059
LOEB GARYEVP & Chief Legal and Complian
2245
0.0006%
$1.22M03
Ladd Amy Ldirector
739
0.0002%
$400,050.2609
Widman FredrikVP Corporate Controller
473
0.0001%
$256,053.8206
Brosius MarkSVP & Chief Mfg and Supply Cha
443
0.0001%
$239,813.62038
BARRATT CRAIG Hdirector
0
0%
$0015
Curet MyriamEVP & Chief Medical Officer
0
0%
$0064
MOLL FREDERIC Hdirector
657799
0.1841%
$356.09M02
SMITH LONNIE Mdirector
281414
0.0788%
$152.34M068
BARNES SUSAN KFormer CFO
100236
0.0281%
$54.26M01
MOHR MARSHALLExecutive VP Global Business S
26877
0.0075%
$14.55M049
LEVY ALAN Jdirector
25319
0.0071%
$13.71M031
RUBASH MARK Jdirector
16051
0.0045%
$8.69M021
MELTZER MARK JSVP General Counsel & CCO
10052
0.0028%
$5.44M029
Gong Benjamin BVice President, Finance
6090
0.0017%
$3.3M01
LOOP FLOYD D MDdirector
4979
0.0014%
$2.7M06
Andersen Reiter KaraSr VP General Counsel & CCO
4844
0.0014%
$2.62M07
Friedman Michael Adirector
4751
0.0013%
$2.57M04
Brogna SalvatoreEVP & Chief Operating Officer
4143
0.0012%
$2.24M030
MCNAMARA JEROME JSr Advisor - Commercial Ops
3213
0.0009%
$1.74M042
HALVORSON ERIC Hdirector
2485
0.0007%
$1.35M023
STALK GEORGE JRdirector
814
0.0002%
$440,650.7604
Leonard Keith Rdirector
849
0.0002%
$459,597.6603
RUNKEL JOHN F JRFormer VP(SR)-General Counsel
403
0.0001%
$218,160.0209
DUGGAN ROBERT Wdirector
0
0%
$0056
MERCER WILLIAM Jdirector
0
0%
$002
GROSSMAN D KEITHdirector
0
0%
$009
MILLER ERICSr. Vice President
0
0%
$0010
KRAMER RICHARD Jdirector
0
0%
$0017
Morales ColinGM & SVP Secondary Mkt Equip &
124
0%
$67,126.16013
Castello Augusto V.SVP Product Ops
0
0%
$002
*Gray background shows insiders who have made transactions during last year

ISRG Institutional Investors: Active Positions

Increased Positions1,020+41.68%20M+6.77%
Decreased Positions1,067-43.6%24M-7.83%
New Positions145New2MNew
Sold Out Positions257Sold Out3MSold Out
Total Postitions2,400-1.92%298M-1.06%

ISRG Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$18.88M9.49%33.6M+263,828+0.79%2025-09-30
Blackrock, Inc.$17.73M8.91%31.54M+27,349+0.09%2025-09-30
State Street Corp$8.73M4.39%15.54M-12,876-0.08%2025-09-30
Price T Rowe Associates Inc /Md/$7.2M3.62%12.82M-596,681-4.45%2025-09-30
Geode Capital Management, Llc$4.65M2.34%8.27M+84,991+1.04%2025-09-30
Capital World Investors$4.34M2.18%7.73M+116,034+1.52%2025-09-30
Morgan Stanley$3.54M1.78%6.3M+198,070+3.25%2025-09-30
Fmr Llc$2.81M1.41%5M-4M-42.26%2025-09-30
Norges Bank$2.66M1.34%4.73M+127,120+2.76%2025-06-30
Bank Of New York Mellon Corp$2.32M1.17%4.12M-394,179-8.73%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.